Mizuho Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Mizuho Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$73K	Sell	1,071 -216	-17%	-$15.2K	0.02%	541
2016 Q2	$71K	Buy	+1,287	New	+$81.1K	0.01%	610
2016 Q1	–	Sell	-816	Closed	-$77K	–	659
2015 Q4	$77K	Hold	816	–	–	0.02%	590
2015 Q3	$66K	Buy	816 +131	+19%	+$14.6K	0.02%	570
2015 Q2	$82K	Buy	+685	New	+$81.9K	0.02%	487

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Mizuho Asset Management's ALNY Position: Q3 2016 in Review

Mizuho Asset Management reduced its Alnylam Pharmaceuticals (ALNY) stake by 17% in Q3 2016, selling an estimated $15.2K and leaving 1,071 shares worth $73K. The position accounts for 0.02% of the portfolio, ranked #541.

Mizuho Asset Management first reported a position in ALNY in Q2 2015 and has held it in 5 quarters since. The position peaked at $82K in Q2 2015. 259 funds tracked by Wall St. Rank hold ALNY as of Q3 2016.

Mizuho Asset Management held 1,071 shares of Alnylam Pharmaceuticals worth $73K as of Q3 2016.
Mizuho Asset Management sold 216 Alnylam Pharmaceuticals shares in Q3 2016, an estimated $15.2K.
Alnylam Pharmaceuticals made up 0.02% of Mizuho Asset Management's portfolio in Q3 2016, its #541 holding.
Mizuho Asset Management first reported a position in Alnylam Pharmaceuticals in Q2 2015 and has held it in 5 quarters since.
Mizuho Asset Management's Alnylam Pharmaceuticals position peaked at $82K in Q2 2015.
259 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.